Yuri M. Sheinin

Dr. Yuri M. Sheinin is an Associate Professor at the Medical College of Wisconsin, specializing in breast, urologic, and pulmonary pathology. He actively teaches medical students and residents, contributing to both clinical and academic settings. His research focuses on breast cancer precursors, prognostic/predictive factors, and immune checkpoint inhibitors in urologic malignancies. Dr. Sheinin obtained his MD and PhD in Pathology from Belarussian State Medical University, followed by residency training at the University of Nebraska Medical Center and fellowships in breast pathology (Northwestern University) and surgical pathology (University of Minnesota).

Educational Background:

• Doctor of Medicine – Belarussian State Medical University
• Doctor of Philosophy in Pathology – Belarussian State Medical University
• Internship in Anatomic Pathology – Minsk Regional Hospital
• Residency in Anatomic Pathology – University of Nebraska Medical Center
• Fellowship in Breast Pathology – Northwestern University
• Fellowship in Surgical Pathology – University of Minnesota

Research Interests: His work emphasizes translational research in oncologic pathology, particularly the molecular mechanisms of tumor progression and therapy response. Dr. Sheinin investigates biomarkers for personalized treatment strategies in breast and urologic cancers, as well as immune-related pathologies such as those observed in SARS-CoV-2 pneumonitis. His studies often involve collaborations with clinicians and basic scientists to bridge diagnostic and therapeutic gaps.

Publications Overview: Dr. Sheinin’s recent work spans tumor metabolism (e.g., MAPK signaling in pancreatic cancer), immunotherapy-associated pathologies (e.g., nivolumab-induced granulomas), and SARS-CoV-2 lung pathology. His contributions highlight both basic science and clinical applications, with a focus on novel biomarkers and diagnostic challenges in complex cases.

Teaching & Mentoring: He mentors medical students and residents in anatomical pathology, emphasizing diagnostic rigor and emerging techniques in molecular diagnostics. No formal grants or named awards are listed, though his extensive publication record reflects sustained research activity.

Languages: Fluent in English, Hebrew, and Italian.